P34.03 A ‘Plasma-First’ Molecular Profiling Approach Complements Actionable Mutation Detection in Suspected Lung Cancer Patients

Abstract

Tissue biopsy and associated molecular profiling is an integral part of the diagnostic approach to suspected lung cancer. It is however invasive, slow and associated with limitations of tissue heterogeneity. The ‘plasma-first’ paradigm of liquid biopsy may complement diagnosis in providing additional information and may be particularly helpful in patients from whom obtaining tissue is challenging.